Trial intelligence / Profile preview

Real-world study of pyrotinib in HER2-positive breast cancer

ChiCTR1900021819Phase 4Not yet recruiting

Sponsor

Affiliated Cancer Hospital of Nanjing Medical University

Start

Mar 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1